Eribulin Advanz Pharma

Eribulin Mesylate is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth. Learn more about Eribulin Mesylate uses and effects.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is designed to target and destroy cancer cells. This medication is often considered when other treatments have not been effective. Eribulin Mesylate is part of a class of drugs known as microtubule dynamics inhibitors, which interfere with the cell division process.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some individuals may also experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. It is important to discuss any persistent or severe side effects with a healthcare provider.

Eribulin Mesylate should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines when using this medication. Patients should be monitored regularly for any signs of adverse reactions. Pregnant women or those planning to become pregnant should consult a healthcare provider before using Eribulin Mesylate.

Eribulin Mesylate may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.